People · Operator
Named in public records as an officer, director or promoter · active 2015–2024 · Other Energy, Other Technology, Biotech / Pharma, Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Goldman Sachs Renewable Power LLC | — | Other Energy | Growth/Late | $1.5B | $18.4B | 2018 |
| Tiz, Inc. | — | Other Technology | Series B | $38.0M | $311.4M | 2023 |
| Oisin Biotechnologies, Inc. | — | Biotech / Pharma | Series A | $18.4M | $28.1M | 2020 |
| OncoSenX, Inc. | — | Other | Series A | $4.8M | $7.2M | 2017 |
| MedicSana Inc. | — | Other | Pre-Seed | $200K | $4.6M | 2015 |
| Entos Pharmaceuticals Inc. | — | Pharmaceuticals | Pre-Seed | $100K | $4.7M | 2020 |
John Lewis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Lewis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gary Hudson | 2 | 3 |
| Eric Garcia | 2 | 3 |
| Matthew Scholz | 2 | 3 |
| Stephen Hilbert | 2 | 2 |
| Kent Bennett | 1 | 14 |
| Corey Ferengul | 1 | 6 |
| Andrew Johnson | 1 | 5 |
| Ian Loizeaux | 1 | 3 |
| James Knapp | 1 | 3 |
| Antal Desai | 1 | 3 |
| Charles Robbins | 1 | 2 |
| Danjuma Quarless | 1 | 1 |
| Steve Hilbert | 1 | 1 |
| Mike Tully | 1 | 1 |
| Taylor Katzman | 1 | 1 |
| Andries Zijlstra | 1 | 1 |
| Roy Duncan | 1 | 1 |
| Arun Raturi | 1 | 1 |
| Andrew Galloway | 1 | 1 |
| Alejandro Castillo | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.